phlebotomy training boston phlebotomy training mn phlebotomist courses
Thursday 27 June 2013
Study Finds Investigational Compound Empagliflozin Reduced Blood Glucose In Adults With Type 2 Diabetes And Impaired Kidney Function
Data presented at American Diabetes Association 73rd Scientific Sessions� also showed reductions in weight and blood pressure Boehringer Ingelheim and Eli Lilly and Company have announced results of a 52week Phase III clinical trial of the investigational compound empagliflozin*, which showed statistically significant reductions in HbA1c (average blood glucose) at week 24, with the addition of empagliflozin to existing oral glucoselowering therapy in people with Type 2 Diabetes (T2D) and mild to moderate renal impairment as measured by the estimated glomerular filtra... (Source: Health News from Medical News Today)
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment